Thesis (Ph. D.)--University of Texas at Austin, 2007. / Vita. Includes bibliographical references.

No description available.

The synthesis of polyesters and copolyesters containing the bicycl o[2. 2.2]octane ring and 1,4-cycl ohexanedi acetic acid and 1,4-cyclohexanedimethanol spacers are discussed. The following homopolyesters were synthesized: poly[oxy(2-methyll, 4-phenylene)oxycarbonyl-l,4-bicyclo[2.2.2]octylenecarbonyl] I; and poly[oxy(2-chloro-l,4-phenylene)oxycarbonyl-l,4-bicyclo[2.2.2]octy-1 enecarbonyl] II. The following copolyesters were synthesized: poly[oxy (2-chl oro- 1,4-phenyl ene )oxycarbonyl-l ,4-bi cycl o[2. 2. 2]octyl enecarbonyl-co-oxy- (2-chloro-1,4-phenylene)oxysebacoyl] III; poly[oxy(2-methyl-l,4- phenylene)oxycarbonyl-l,4-bicyclo[2.2.2]octylene-co-oxy(2-methyl-l,4- phenyl ene)oxysebacoyl] IV; poly[oxy(2-methyl-l,4-phenylene)oxyterephthaloyl- co-oxy(2-methyl-l,4-phenylene)oxy-l,4-cyclohexanediacetoyl] V; poly[oxy(2-methyl-1,4-phenylene)oxyterephthaloyl-co-oxymethylene-1,4 cyclohexylenemethyleneoxyterephthaloyl] VI; and poly[oxy(2-chloro-1,4 phenylene)oxyterephthaloyl-co-oxymethylene-1,4 cyclohexylenemethyleneoxyterephthaloyl]VII. The resulting homopolyesters and copolyesters were characterized by proton NMR, DSC, TGA, IR, solution viscosity, and polarizing optical microscopy.

Abstract Synthetic routes were developed for the preparation of 2-alkoxy-4-hydroxybenzoic acids and 2-alkoxyhydroquinones, and a large-scale synthesis was developed for the preparation of 2-thioalkoxyhydroquinones. The 2-alkoxy-4-hydroxybenzoic acids, which contained alkyl side chains of different length, were used in the synthesis of new main chain liquid crystalline (LC) homo-, random, and block co-oligomers. In addition, oligomers of terephthaloyl chloride and 2-thioalkoxyhydroquinones and oligomers of terephthaloyl chloride and 2-alkoxyhydroquinones were produced. All the oligomers were blended with aliphatic polyamide 11 (PA 11). The effect of alkyl side chain length on the compatibility behavior of the LC oligomers towards the aliphatic polymer was characterized by DSC and FTIR, and the effect of side chain length on the flexural properties of the blends was investigated with a three-point bending test. The miscibility studies showed variable interfacial adhesion between the blended compounds. The strongest adhesion was achieved between PA 11 and the homo-oligomers of 2-alkoxy-4-hydroxybenzoic acids with short or medium long substituents (C4-C10), but the interactions between PA 11 and the oligomer with long aliphatic side chain (C18) were poor, as were those between PA 11 and the wholly aromatic oligomer of 4-hydroxybenzoic acid. The compatibility between PA 11 and the co-oligomers of 2-alkoxy-4-hydroxybenzoic acids was slightly lower than the compatibility of the corresponding homo-oligomers. DSC and FTIR analyses of the blends of oligomers of terephthaloyl chloride and 2-thioalkoxyhydroquinones and oligomers of terephthaloyl chloride and 2-alkoxyhydroquinones with PA 11 implied that the interactions between the blended compounds were poor. FTIR spectra and viscosity measurements confirmed that all the oligomeric structures could self-associate, with effect on the final mechanical properties of the polyamide. The strength of PA 11 in a three-point bending test was increased by the addition of only 1% of LC oligomers to the matrix. The results also showed that the strengthening ability of the oligomers is directly proportional to the total amount of aliphatic carbons. The best strengthening results were obtained with unsubstituted oligomers, random co-oligomers of 2-alkoxy-4-hydroxybenzoic acids, and homo-oligomer of 2-butoxy-4-hydroxybenzoic acid. DSC investigations of a ternary blend of the oligomer of 2-decanyloxy-4-hydroxybenzoic acid, PA 11, and wholly aromatic commercial LC polymer showed the promising compatibilizing effect of the oligomer.

No description available.

No description available.

No description available.

Soft materials have attracted much scientific and technical interest in recent years. In this thesis, attention has been placed on the underpinning relations between molecular structure and properties of one type of soft matter - main chain liquid crystalline elastomers (MCLCEs), which may have application as shape memory or as auxetic materials. In this work, a number of siloxane-based MCLCEs and their linear polymer analogues (MCLCPs) with chemical variations were synthesized and examined. Among these chemical variations, rigid p-phenylene transverse rod and flat-shaped anthraquinone (AQ) mesogenic monomers were specifically incorporated. Thermal and X-ray analysis found a smectic C phase in most of our MCLCEs, which was induced by the strong self-segregation of siloxane spacers, hydrocarbon spacers and mesogenic rods. The smectic C mesophase of the parent LCE was not grossly affected by terphenyl transverse rods. Mechanical studies of MCLCEs indicated the typical three-region stress-strain curve and a polydomain-to-monodomain transition. Strain recovery experiments of MCLCEs showed a significant dependence of strain retentions on the initial strains but not on the chemical variations, such as the crosslinker content and the lateral substituents on mesogenic rods. The MCLCE with p-phenylene transverse rod showed a highly ordered smectic A mesophase at room temperature with high stiffness. Mechanical properties of MCLCEs with AQ monomers exhibit a strong dependence on the specific combination of hydrocarbon spacer and siloxane spacer, which also strongly affect the formation of ð-ð stacking between AQ units. Poisson s ratio measurement over a wide strain range found distinct trends of Poisson s ratio as a function of the crosslinker content as well as terphenyl transverse rod loadings in its parent MCLCEs.

O processo de interferência de RNA refere-se ao silenciamento pós transcricional seqüência-específico de genes em animais e plantas capaz de ser promovido por dsRNA homólogo à seqüência do gene silenciado. Este processo pode ser aplicado como terapia, que apresenta como vantagens a especificidade pelos alvos escolhidos, a possibilidade de tratar uma enorme gama de doenças genéticas, além do fato de ser muito potente e eficaz. Contudo, o principal desafio consiste em manter a estabilidade dos siRNAs nos fluidos biológicos, visto que estes são bastante susceptíveis à excreção renal e a degradação por RNAses. Com isso, reforça-se a necessidade de sistemas de liberação adequados, que sejam capazes de manter a estabilidade dos siRNAs por tempo suficiente para que atinjam os órgãos alvo da terapia e promover sua liberação sustentada. De particular interesse são determinadas proteínas e peptídeos de transdução (PTDs) que podem ser ligados a fármacos hidrofílicos e assim tornam possível com que estes atravessem membranas. Neste sentido, muitos sistemas carreadores não-virais tem sido estudados para a veiculação de siRNA, sendo de cunho inovador o desenvolvimento de sistemas de liberação nanoestruturados baseados em cristais líquidos funcionalizados com peptídeos de transdução de membrana para a veiculação tópica de siRNAs. Desta forma, nanopartículas de cristais líquidos de fase hexagonal contendo ou não os aditivos catiônicos polietileimina (PEI) e oleilamina (OAM) foram funcionalizadas com peptídeos de transdução de membranas TAT (TAT) ou penetratin (PNT). Os sistemas obtidos foram complexados com siRNA por interação eletrostática e caracterizados através de medidas de tamanho de partícula/ polidispersividade, potencial zeta e eficiência de complexação. A citotoxicidade dos sistemas foi avaliada em fibroblastos L929 pelo ensaio do MTT e por citometria de fluxo e a avaliação da transfecção in vitro foi realizada por citometria de fluxo e por microscopia de fluorescência. Os sistemas contendo PEI ou OAM apresentavam potencial zeta positivo e foram capazes de complexar o siRNA adicionado na concentração de 10 ?M. Os estudos em culturas celulares demonstraram que os sistemas contendo ácido oleico (AO) foram mais eficientes quanto à transfecção em células de fibroblastos L929 e esta eficiência de transfecção foi aumentada com a funcionalização com o peptídeo TAT. A partir daí, os sistemas selecionados foram avaliados quanto a penetração cutânea in vivo. Os sistemas nanodispersos formados por MO/AO/PEI proporcionaram uma maior liberação de siRNA na pele e a eficiência de supressão de TNF-alfa em modelo animal de inflamação cutânea foram maiores que formulações controle. Com isso, demonstrou-se que os sistemas desenvolvidos são promissores para a futura aplicação na terapia gênica tópica de doenças cutâneas inflamatórias. / The RNA interference process refers to the sequence-specific posttranscriptional silencing of genes in animals and plants capable of being promoted by dsRNA that are homologous to the sequence of the silenced gene. This process can be applied as therapy, which presents advantages such as the specificity to the chosen targets, the possibility to treat a variety of genetic diseases, besides being very potent and efficacious. However, the major hurdle consists in keeping the siRNAs stability in the biological fluids, because they are susceptible to renal clearance and degradation by RNAses. Thus, there is the need for suitable delivery systems, capable of maintaining the stability of siRNAs for sufficient time so they can reach the target organ in the therapy and promote sustained release. Of particular interest are certain proteins and peptides transduction domains (PTDs) that can be connected to hydrophilic drugs and thus make it possible to cross cell membranes. Within this context, many non-viral vectors have been studied for siRNA vehiculation which makes innovative the present study because it aims at the development of nanostructured delivery systems based on liquid crystals functionalyzed with membrane transduction peptides for the topical vehiculation of siRNAs. Thus, hexagonal phase liquid crystal nanoparticles containing or not the cationinc polyethylenimine (PEI) and oleylamine (OAM) were functionalyzed with membrane transduction peptides TAT (TAT) or penetratin (PNT). The obtained systems were complexed with siRNA by eletrostatic interaction and characterized for particle size, polidispersity, zeta potential and complexation efficiency. The cytotoxicity of the formulations was performed with L929 fibroblasts by MTT assay and flow cytometry and the in vitro transfection was evaluated by flow cytometry and fluorescence microscopy. The systems containing PEI or OAM presented positive zeta potential and could complex siRNA at the concentration of 10 ?M. The cell culture studies demonstrated that the systems containing oleic acid (OA) were the most efficient to transfect L929 cells and the transfection efficiency was enhanced with the functionalization with the TAT peptide. Thereafter, the selected systems were evaluated for the in vivo skin penetration. The nanosdispersed systems composed of MO/OA/PEI functionalyzed with TAT resulted in a higher siRNA penetration and release in the skin, promoting higher TNF alfa supression in animal model of cutaneous inflammation, compared to the control formulations. Hence, we demonstrated that the developed systems are promising for the treatment of inflammatory skin diseases.

O processo de interferência de RNA refere-se ao silenciamento pós transcricional seqüência-específico de genes em animais e plantas capaz de ser promovido por dsRNA homólogo à seqüência do gene silenciado. Este processo pode ser aplicado como terapia, que apresenta como vantagens a especificidade pelos alvos escolhidos, a possibilidade de tratar uma enorme gama de doenças genéticas, além do fato de ser muito potente e eficaz. Contudo, o principal desafio consiste em manter a estabilidade dos siRNAs nos fluidos biológicos, visto que estes são bastante susceptíveis à excreção renal e a degradação por RNAses. Com isso, reforça-se a necessidade de sistemas de liberação adequados, que sejam capazes de manter a estabilidade dos siRNAs por tempo suficiente para que atinjam os órgãos alvo da terapia e promover sua liberação sustentada. De particular interesse são determinadas proteínas e peptídeos de transdução (PTDs) que podem ser ligados a fármacos hidrofílicos e assim tornam possível com que estes atravessem membranas. Neste sentido, muitos sistemas carreadores não-virais tem sido estudados para a veiculação de siRNA, sendo de cunho inovador o desenvolvimento de sistemas de liberação nanoestruturados baseados em cristais líquidos funcionalizados com peptídeos de transdução de membrana para a veiculação tópica de siRNAs. Desta forma, nanopartículas de cristais líquidos de fase hexagonal contendo ou não os aditivos catiônicos polietileimina (PEI) e oleilamina (OAM) foram funcionalizadas com peptídeos de transdução de membranas TAT (TAT) ou penetratin (PNT). Os sistemas obtidos foram complexados com siRNA por interação eletrostática e caracterizados através de medidas de tamanho de partícula/ polidispersividade, potencial zeta e eficiência de complexação. A citotoxicidade dos sistemas foi avaliada em fibroblastos L929 pelo ensaio do MTT e por citometria de fluxo e a avaliação da transfecção in vitro foi realizada por citometria de fluxo e por microscopia de fluorescência. Os sistemas contendo PEI ou OAM apresentavam potencial zeta positivo e foram capazes de complexar o siRNA adicionado na concentração de 10 ?M. Os estudos em culturas celulares demonstraram que os sistemas contendo ácido oleico (AO) foram mais eficientes quanto à transfecção em células de fibroblastos L929 e esta eficiência de transfecção foi aumentada com a funcionalização com o peptídeo TAT. A partir daí, os sistemas selecionados foram avaliados quanto a penetração cutânea in vivo. Os sistemas nanodispersos formados por MO/AO/PEI proporcionaram uma maior liberação de siRNA na pele e a eficiência de supressão de TNF-alfa em modelo animal de inflamação cutânea foram maiores que formulações controle. Com isso, demonstrou-se que os sistemas desenvolvidos são promissores para a futura aplicação na terapia gênica tópica de doenças cutâneas inflamatórias. / The RNA interference process refers to the sequence-specific posttranscriptional silencing of genes in animals and plants capable of being promoted by dsRNA that are homologous to the sequence of the silenced gene. This process can be applied as therapy, which presents advantages such as the specificity to the chosen targets, the possibility to treat a variety of genetic diseases, besides being very potent and efficacious. However, the major hurdle consists in keeping the siRNAs stability in the biological fluids, because they are susceptible to renal clearance and degradation by RNAses. Thus, there is the need for suitable delivery systems, capable of maintaining the stability of siRNAs for sufficient time so they can reach the target organ in the therapy and promote sustained release. Of particular interest are certain proteins and peptides transduction domains (PTDs) that can be connected to hydrophilic drugs and thus make it possible to cross cell membranes. Within this context, many non-viral vectors have been studied for siRNA vehiculation which makes innovative the present study because it aims at the development of nanostructured delivery systems based on liquid crystals functionalyzed with membrane transduction peptides for the topical vehiculation of siRNAs. Thus, hexagonal phase liquid crystal nanoparticles containing or not the cationinc polyethylenimine (PEI) and oleylamine (OAM) were functionalyzed with membrane transduction peptides TAT (TAT) or penetratin (PNT). The obtained systems were complexed with siRNA by eletrostatic interaction and characterized for particle size, polidispersity, zeta potential and complexation efficiency. The cytotoxicity of the formulations was performed with L929 fibroblasts by MTT assay and flow cytometry and the in vitro transfection was evaluated by flow cytometry and fluorescence microscopy. The systems containing PEI or OAM presented positive zeta potential and could complex siRNA at the concentration of 10 ?M. The cell culture studies demonstrated that the systems containing oleic acid (OA) were the most efficient to transfect L929 cells and the transfection efficiency was enhanced with the functionalization with the TAT peptide. Thereafter, the selected systems were evaluated for the in vivo skin penetration. The nanosdispersed systems composed of MO/OA/PEI functionalyzed with TAT resulted in a higher siRNA penetration and release in the skin, promoting higher TNF alfa supression in animal model of cutaneous inflammation, compared to the control formulations. Hence, we demonstrated that the developed systems are promising for the treatment of inflammatory skin diseases.